Status Epilepticus Associated with Borage Oil Ingestion

Journal of Medical Toxicology - Tập 7 - Trang 154-157 - 2011
Wafa’a A. Al-Khamees1,2, Michael D. Schwartz1,2, Saleh Alrashdi1,3, Adam D. Algren4, Brent W. Morgan1,2,5
1Georgia Poison Center, Grady Health System, Atlanta, USA
2Emory University School of Medicine, Atlanta, USA
3
4Departments of Emergency Medicine and Pediatrics, Truman Medical Center and Children’s Mercy Hospital, University of Missouri–Kansas City School of Medicine, Kansas City, USA
5Atlanta, USA

Tóm tắt

The use of herbal and complementary medicine is common. Many herbal products are known to produce serious adverse effects. Borage oil is derived from the seeds of the borage plant (Borago officinalis) an abundant source of gamma-linolenic acid (GLA), and Borage oil has been promoted as a treatment for rheumatoid arthritis, atopic dermatitis, diabetic neuropathy, and menopause-related symptoms. We report a case of status epilepticus in a patient who consumed borage oil for one week.

Tài liệu tham khảo

Spinella M (2001) Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav 2(6):524–532 Tyagi A, Delanty (2003) Herbal remedies, dietary supplements, and seizures. Epilepsia 44(2):228–235 Abbot NC, Ernst E (1997) Patients’ opinions about complementary medicine. Forschende Komplementrmedizin 4:164–168 Ernst E, White A (2000) The BBC survey of complementary medicine use in the UK. Complement Ther Med 8:32–36 Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287:337–344 Peebles CT, McAuley JW, Roach J, Moore JL, Reeves AL (2000) Alternative medicine use by patients with epilepsy. Epilepsy Behav 1:74–77 Barre D (2001) Potential of evening primrose, borage, black currant, and fungal oils in human health. Ann Nutr Metab 45(2):47–57 Belch J, Hill A (2000) Evening primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr 71(suppl):352S–356S Greene JF, Hammock BD (1999) Toxicity of linoleic acid metabolites. Adv Exp Med Biol 469:471–477 Vermunt SHF, Mensink RP, Simonis MMG, Wagenmakers AJM, Hornstra G (2001) The metabolism of linoleic acid in health subjects after intake of a single dose of 13 C linoleic acid. Eur J Clin Nutr 55:321–326 Vaddadi KS (1981) The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia. Prostaglandins Med 6(4):375–379 Holman C, Bell A (1983) A trial of evening primrose oil in the treatment of chronic schizophrenia. J Orthomol Psychiatry 12:302–304 Puri BK (2007) The safety of evening primrose oil in epilepsy. Prostaglandins Leukot Essent Fat Acids 77(2):101–103, Epub 2007 Aug 30 Miller LG (1998) Herbal medicinals: selected clinical considerations focusing on known or potential drug–herb interactions. Arch Intern Med 158:2200–2211 Guillen MD, Goicoechea E (2008) Toxic oxygenated α, β-unsaturated aldehydes and their study in foods: a review. Crit Rev Food Sci Nutr 48:119–136 Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxy-2-nonenal, malonaldehyde and related aldehydes. Free Radical Biol Méd 11:81–128 Yen CH (2008) Linoleic acid metabolite levels and transepidermal water loss in children with atopic dermatitis. Ann Allergy Asthma Immunol 100:66–73 Martens-Lobenhoffer J, Meyer FP (1998) Pharmacokinetic data of gamma-linolenic acid in healthy volunteers after the administration of evening primrose oil. Int J Clin Pharmacol Therap 36(7):363–366 Pilitsis JG, Coplin WM, Regan MH et al (2003) Free fatty acids in cerebrospinal fluid from patients with traumatic brain injury. Neurosci Lett 349:136–138